Nonalcoholic steatohepatitis/nonalcoholic fatty liver disease is considered to be a hepatic manifestation of various metabolic disorders. However, its precise pathogenic mechanism is obscure. Oxidative stress and consequent lipid peroxidation seem to play a pivotal role in disease progression. In th
The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome
โ Scribed by Onpan Cheung; Ashwani Kapoor; Puneet Puri; Sakita Sistrun; Velimir A. Luketic; Carol C. Sargeant; Melissa J. Contos; Mitchell L. Shiffman; Richard T. Stravitz; Richard K. Sterling; Arun J. Sanyal
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 211 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Previous studies examining the relationship between hepatic iron deposition and histological severity in nonalcoholic fatty liver disease (NAFLD) have been inconclusive. The goal of this study was to examine the relationship between hepatic iron deposition and liver histology in 849 patients enrolle
A high-fat diet causes activation of the regulatory protein c-Jun NH2-terminal kinase 1 (JNK1) and triggers development of insulin resistance. JNK1 is therefore a potential target for therapeutic treatment of metabolic syndrome. We explored the mechanism of JNK1 signaling by engineering mice in whic
We read with great interest the article by Petta et al. 1 The compound 25-hydroxyvitamin D3 (25[OH]D3) was reported as an independent predictor of cardiovascular disease (by a decreased expression of profibrotic markers, and an increased expression of antifibrotic markers) despite the fact that its